Health
Arthritis drug trialled as potential treatment for COVID-19 – Arab News
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19. The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foun…
LONDON: The experimental arthritis drug, otilimab, is being trialled as a potential treatment for COVID-19.
The first patient, administered with the drug, is currently being cared for at Manchester Royal Infirmary (MRI), part of Manchester University NHS Foundation Trust (MFT).
The OSCAR study (Otilimab in Severe COVID-19 Related Disease) is sponsored and funded by the pharmaceutical company GlaxoSmithKline.
The study at the MRI is being led by Dr. Andy Martin, an Intensive Care and Anaest…
-
General20 hours agoOf saints and sinners | The Spectator Australia
-
General21 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire
-
Noosa News11 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General21 hours agoWhy the nation needs the Nationals to ditch Net Zero